Published May 1997 | Version Published
Journal Article Open

Cyclic nucleotide-gated channels: structural basis of ligand efficacy and allosteric modulation

Abstract

Most working proteins, including metabolic enzymes, transcription regulators, and membrane receptors, transporters, and ion channels, share the property of allosteric coupling. The term 'allosteric' means that these proteins mediate indirect interactions between sites that are physically separated on the protein. In the example of ligand-gated ion channels, the binding of a suitable ligand elicits local conformational changes at the binding site, which are coupled to further conformational changes in regions distant from the binding site. The physical motions finally arrive at the site of biological activity: the ion-permeating pore. The conformational changes that lead from the ligand binding to the actual opening of the pore comprise 'gating'. In 1956, del Castillo and Katz suggested that the competition between different ligands at nicotinic acetylcholine receptors (nAChRs) could be explained by formation of an intermediate, ligand-bound, yet inactive state of the receptor, which separates the active state of the receptor from the initial binding of the ligand (del Castillo & Katz, 1957). This 'binding-then-gating', two-step model went beyond the then-prevailing drug-receptor model that assumes a single bimolecular binding reaction, and paralleled Stephenson's conceptual dichotomy of 'affinity' and 'efficacy' (Stephenson, 1956). In 1965 Monod, Wyman and Changeux presented a simple allosteric model (the MWC model) (Monod et al. 1965) that explained the cooperative binding of oxygen to haemoglobin; it was adopted as an important paradigm for ligand-gated channels soon after its initial formulation (Changeux et al. 1967; Karlin, 1967; Colquhoun, 1973).

Additional Information

© 1997 Cambridge University Press. Reprinted with permission. The authors thank members of the Zagotta laboratory for stimulating discussions. Sela Mager, Mark Nowak, Yinong Zhang and Jing Liu read the manuscript critically. The preparation of this review is supported by research grants from the National Institute of Health: EY-10329, MH-49176, GM-29836, and by predoctoral training grant GM-08501. W.N.Z. is an Investigator of the Howard Hughes Medical Institute.

Attached Files

Published - LIJqrb97.pdf

Files

LIJqrb97.pdf

Files (669.4 kB)

Name Size Download all
md5:87263685dc60cc5c135321cffc429ed6
669.4 kB Preview Download

Additional details

Identifiers

Eprint ID
4317
Resolver ID
CaltechAUTHORS:LIJqrb97

Funding

NIH
EY-10329
NIH
MH-49176
NIH
GM-29836
NIH Predoctoral Fellowship
GM-08501
Howard Hughes Medical Institute (HHMI)

Dates

Created
2006-08-17
Created from EPrint's datestamp field
Updated
2019-10-02
Created from EPrint's last_modified field